Mental Healthcare News and Resources for Healthcare

How To Leverage Data Analytics to Improve Suicide Risk Assessments

February 20, 2024 - Behavioral workforce shortages and access barriers to mental healthcare continue to drive the United States’ mental health crisis, leaving many at risk for adverse outcomes like suicide without the care they need. Health systems play a pivotal role in closing these gaps and improving outcomes, but preventing suicides remains a challenge. Kimberly Roaten, PhD, ABPP, Professor in...

Integrating Doulas Into Maternal Mental Healthcare, Care Teams

December 15, 2023 by Editorial Staff

As part of its overall mission to improve health equity, NewYork-Presbyterian is host to a program aimed at improving maternal mental health and, in particular, closing race-based disparities in maternal mental health. According to the...

How to Coordinate Mental Healthcare, Physical Care Amid High Demand

November 28, 2023 by Editorial Staff

The demand for mental health has increased significantly in the 2020s. Mental healthcare utilization grew 38.8 percent between 2019 and 2022 and spending on mental health jumped 53.7 percent in the...

Future of Telehealth, Hybrid Care After the Public Health Emergency

November 21, 2023 by Kelsey Waddill

Now that the coronavirus pandemic has become more manageable, how has the evolution of telehealth taken shape and how can the industry improve hybrid care? When the coronavirus pandemic gripped the...

How Access to Reproductive Mental Health Can Improve Maternal Health

September 18, 2023 by Kelsey Waddill

In this episode of Healthcare Strategies, Associate Editor Veronica Salib chats with Dr. Sarah Oreck, a reproductive psychiatrist and co-founder of Mavida Health about the comprehensive reproductive mental health program. The...

Exploring Pros & Cons of Direct-to-Consumer Virtual Mental Health Apps

July 03, 2023 by Anuja Vaidya

Characterized by economic and financial instability, political uncertainty, social isolation, and widespread illness and death, the COVID-19 pandemic left Americans' mental health in tatters. The...

Exploring Mental Health Treatment, Adherence Challenges, Solutions

June 26, 2023 by Alivia Kaylor

In this episode of Healthcare Strategies, Colin Banas, MD, MSHA, Chief Medical Officer at DrFirst, discusses the importance of mental health treatment and the main challenges for medication adherence...

Introducing Gender-Affirming Care to Primary Care Settings, Telehealth Services

December 19, 2022 by Alivia Kaylor

Although primary care clinics offer numerous beneficial healthcare services to patients, they often fall short of delivering effective gender-affirming care (GAC), which requires empathy, trust, and...

Making Medicare Advantage Plans for the LGBTQ+ Community

December 12, 2022 by Kelsey Waddill

For generations, the LGBTQ+ community has faced discrimination in the healthcare system. Seniors in the LGBTQ+ community, in particular, have faced a lifetime of inequity and many now enter some of the...

HHS Fixes ACA Family Glitch, Loses 340B Drug Pricing Program Battle

October 18, 2022 by Hayden Schmidt

US District Judge Rudolph Contreras has ordered the Department of Health and Human Services (HHS) to restore full payments to hospitals and reverse its cuts to the 340B Drug Pricing Program. HHS,...

How to Pursue Behavioral-Physical Healthcare Integration in a VBC Framework

September 26, 2022 by Kelsey Waddill

When MetNetOne Health Solutions established roaming physician teams that would go from practice to practice to help address chronic disease management needs around two decades ago, it became apparent...

Early Alzheimer’s Disease Detection Test Gains Key FDA Approval

May 17, 2022 by Kyle Murphy, PhD

A new tool is coming to market to improve the early detection of Alzheimer's disease by testing cerebral spinal fluid. FDA Greenlights First In-Vitro Alzheimer’s Disease Test FDA...

Coronavirus Vaccination Disparities Widen, FDA Warns Against Baby Formula

March 09, 2022 by Hayden Schmidt

In a promising move for consumers, the Food and Drug Administration (FDA) has accepted an application for Abrilada, a biosimilar that will compete with Humira. Elsewhere within the administration,...

CVS Health to Leverage Community Reach to Expand Clinical Trial Access

February 08, 2022 by Kyle Murphy, PhD

A recent collaboration between CVS Health and Medable looks to make use of the former’s influence in numerous communities to spur greater participation in clinical trials among hard-to-reach...

Strategies to Mitigate the Rising Tide of Self-Medication in the US

January 31, 2022 by Anuja Vaidya

The stress, anxiety, and isolation that come with living through an ongoing pandemic has taken its toll on the mental health of Americans, resulting in a dual healthcare crisis. To cope, a staggering...

Unspent Billions in Provider Relief Fund Likely to Raise Eyebrows

October 28, 2021 by Kyle Murphy, PhD

The revelation that nearly $27 billion remains in the Provider Relief Fund begs the question: Did the federal government do enough to help providers weather the coronavirus pandemic? Analysis Reveals...

Administration Tackles Access to Care, FTC Expands Breach Rule

September 22, 2021 by Hayden Schmidt

The Biden-Harris administration continues its focus on expanding healthcare access as CMS and HHS announce three new initiatives that increase access to Medicare, Medicaid, and maternal care across the...

How Healthcare Professionals Can Break Down Mental Health Stigmas

September 13, 2021 by Kelsey Waddill

As the coronavirus pandemic persists into 2021 and the mental health crisis swells, healthcare stakeholders can take an active role in helping to reduce mental health stigmas. Lana Seiler, primary...

New Funding Supports Pediatric Mental Health, Climate Change, Health Equity

September 01, 2021 by Emily Sokol, MPH

The Office of Climate Change and Health Equity opens under HHS, and several organizations including SAMHSA boost funding for pediatric mental healthcare. This week’s policy recap also highlights...

Controversial Alzheimer’s Drug Under CMS, FDA Watch; EO Looks to Prescription Drug Spending

July 14, 2021 by Emily Sokol, MPH

CMS announced it will begin coverage determination investigations for the controversial Alzheimer’s drug, Aduhelm, while the drug’s approval process is also being investigated by the FDA....

More Articles